Nazlı Zeynep Uslu , Mustafa Hasan Adleh , Ebru Bilir , Fahad al-deen Kata , Merih Kalamanoğlu Balcı
{"title":"Mesalazine-associated lung fibrosis: case report and literature review","authors":"Nazlı Zeynep Uslu , Mustafa Hasan Adleh , Ebru Bilir , Fahad al-deen Kata , Merih Kalamanoğlu Balcı","doi":"10.1016/j.rmcr.2025.102284","DOIUrl":"10.1016/j.rmcr.2025.102284","url":null,"abstract":"<div><h3>Background</h3><div>Even though uncommon, drug-induced interstitial lung disease (DIILD) represents a serious adverse drug reaction. We report a case of a patient with a history of ulcerative colitis who was receiving mesalazine.</div></div><div><h3>Presentation</h3><div>The patient developed dyspnea, hypoxemia, and respiratory failure accompanied by resting oxygen desaturation. Initial CT imaging revealed bilateral perihilar ground-glass opacities along with focal areas of consolidation. Inflammatory markers were elevated, but procalcitonin levels remained persistently low; sputum cultures and multiplex PCR ruled against an infectious origin. Mesalazine was discontinued, and the patient's respiratory status improved dramatically. Follow-up CT revealed interval resolution of the pulmonary lesions, and a diagnosis of DIILD was clinically established.</div></div><div><h3>Conclusion</h3><div>This case emphasizes the importance of balancing clinical suspicion between steroid-related infectious risk and an uncommon drug reaction. We also identified similar Mesalazine-associated DIILD cases in the literature to demonstrate similar radiologic patterns, onset time, and outcomes.</div></div>","PeriodicalId":51565,"journal":{"name":"Respiratory Medicine Case Reports","volume":"58 ","pages":"Article 102284"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145099028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Taiki Hara , Ken Enda , Taku Maeda , Yohei Ikebe , Hideki Ujiie , Masahiro Onozawa
{"title":"Asphyxiation due to obstructive fibrinous tracheal pseudomembrane after closure of repeated tracheostomy in a case of von Recklinghausen disease","authors":"Taiki Hara , Ken Enda , Taku Maeda , Yohei Ikebe , Hideki Ujiie , Masahiro Onozawa","doi":"10.1016/j.rmcr.2025.102298","DOIUrl":"10.1016/j.rmcr.2025.102298","url":null,"abstract":"<div><h3>Background</h3><div>Obstructive fibrinous tracheal pseudomembrane (OFTP) is a rare but potentially fatal complication, most commonly reported after endotracheal intubation. Its occurrence following tracheostomy closure is poorly recognized.</div></div><div><h3>Case presentation</h3><div>We report a fatal case of OFTP in a 33-year-old man with von Recklinghausen disease who developed progressive airway obstruction following closure of a repeated tracheostomy. The patient had a history of multiple facial tumor resections requiring repeated tracheostomies due to orofacial deformities. After the eighth tracheostomy and successful tumor debulking, the tracheal cannula was removed on postoperative day 6. At that time, CT revealed only mild tracheal narrowing without intraluminal obstruction, and the patient remained asymptomatic. However, he was found in cardiopulmonary arrest on postoperative day 14. Postmortem CT showed near-complete tracheal obstruction and pulmonary edema. Autopsy confirmed a grayish-white pseudomembrane obstructing the tracheal lumen, with only a 2-mm residual gap. Histopathology revealed fibrinous exudate with neutrophilic infiltration, consistent with OFTP.</div></div><div><h3>Conclusion</h3><div>This case illustrates that OFTP can occur silently after tracheostomy closure and may lead to sudden death. Vigilant monitoring with CT or bronchoscopy should be considered in high-risk patients with repeated tracheal interventions.</div></div>","PeriodicalId":51565,"journal":{"name":"Respiratory Medicine Case Reports","volume":"58 ","pages":"Article 102298"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145222198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blerina Resuli , Heidi Galarza , Laura Elsner , Diego Kauffmann-Guerrero , Jürgen Behr , Amanda Tufman
{"title":"Safety of brigatinib following alectinib-induced-pneumonitis: Case report","authors":"Blerina Resuli , Heidi Galarza , Laura Elsner , Diego Kauffmann-Guerrero , Jürgen Behr , Amanda Tufman","doi":"10.1016/j.rmcr.2024.102160","DOIUrl":"10.1016/j.rmcr.2024.102160","url":null,"abstract":"<div><div>Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK TKIs) show robust efficacy and has revolutionized the treatment of NSCLC patients harboring an ALK-rearrangement. Side effects, sometimes even serious such as pneumonitis, can occur with ALK TKIs.</div><div>We report a case of a patient with ALK positive advanced NSCLC who developed pneumonitis during treatment with first-line alectinib. With no alternative etiology of pneumonitis identified, the patient was treated with corticosteroids and discontinuation of alectinib. Following rapid clinical recovery and radiographic resolution of the opacities, the patient was started with brigatinib, with no recurrence of the clinical symptoms or radiographic findings of pneumonitis. While further descriptions are needed, our experience suggests that switching to a second ALK-TKI may be a safe therapeutic option in some patients who develop drug-induced pneumonitis on ALK TKIs.</div></div>","PeriodicalId":51565,"journal":{"name":"Respiratory Medicine Case Reports","volume":"53 ","pages":"Article 102160"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743586/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vincent Phan , Syed H. Ali , Brady Olson , Raj Keriwala
{"title":"A stepwise approach for the management of bilateral chylothoraxes from cisterna chyli trauma","authors":"Vincent Phan , Syed H. Ali , Brady Olson , Raj Keriwala","doi":"10.1016/j.rmcr.2025.102218","DOIUrl":"10.1016/j.rmcr.2025.102218","url":null,"abstract":"<div><div>Chylothorax is a rare complication characterized by chyle accumulation in the pleural space, leading to respiratory and nutritional deficits. We present a 53-year-old male who developed bilateral high-output chylothorax following radical nephrectomy and lymph node dissection for renal cell carcinoma. Despite conservative management with a fat-free diet, total parenteral nutrition, and octreotide, chyle output remained >1L/day. Lymphangiography identified thoracic duct leakage, but embolization and cisterna chyli fenestration were unsuccessful. The patient ultimately underwent video-assisted thoracoscopic surgery (VATS) with talc pleurodesis, resulting in resolution. This case highlights the importance of a multidisciplinary, stepwise approach in managing refractory chylothorax, with VATS and talc pleurodesis as effective interventions when conservative therapies fail.</div></div>","PeriodicalId":51565,"journal":{"name":"Respiratory Medicine Case Reports","volume":"55 ","pages":"Article 102218"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143860169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"New onset bronchial asthma following oral propranolol for infantile hemangioma","authors":"Yuki Yamaguchi, Satoshi Horino, Hiroki Miyabayashi, Haruka Aki, Katsushi Miura","doi":"10.1016/j.rmcr.2025.102187","DOIUrl":"10.1016/j.rmcr.2025.102187","url":null,"abstract":"<div><div>Propranolol, a nonselective adrenergic beta-receptor blocker, is the first-line drug used for the treatment of infantile hemangiomas (IH). However, its use is contraindicated in patients with bronchial asthma. Nevertheless, studies assessing whether propranolol triggers asthma in infants and affects asthma control are limited. Here, we report the case of an infant with IH who developed asthma after starting propranolol. Asthma control was refractory to inhaled corticosteroids and leukotriene receptor antagonists, although it improved remarkably with discontinuation of propranolol. This report suggests that infants with a family history of allergic disorders should be monitored for asthma after propranolol administration.</div></div>","PeriodicalId":51565,"journal":{"name":"Respiratory Medicine Case Reports","volume":"54 ","pages":"Article 102187"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143520262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A case study of airway management using laryngeal mask airway combined with Bronchial blocker for surgical treatment of tracheal tumors with pulmonary nodules","authors":"Tingting Hu, Jun Yang, Min Xia","doi":"10.1016/j.rmcr.2025.102208","DOIUrl":"10.1016/j.rmcr.2025.102208","url":null,"abstract":"<div><div>A 60-year-old female with a tracheal tumor near the glottis and a lung nodule underwent surgery for resection. The tumor's proximity to the glottis prevented the safe use of a tracheal tube, as it risked crossing the tumor and causing injury. Given this challenge, a 4<sup>#</sup> single-lumen laryngeal mask airway (LMA) was used in combination with a 9<sup>#</sup> bronchial blocker to achieve one-lung ventilation. This approach minimized the risk of tracheal injury, bleeding, and tumor dissemination. The procedure, including the resection of the lung nodule and tracheal tumor, was completed successfully, with stable postoperative recovery. This case demonstrates the efficacy of LMA and bronchial blocker in complex airway management.</div></div>","PeriodicalId":51565,"journal":{"name":"Respiratory Medicine Case Reports","volume":"55 ","pages":"Article 102208"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143834923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JinFeng Chen , Min Ao , WeiYi Li , Xian Li , Li Yang
{"title":"Primary pulmonary malignant melanoma with multiple metastases: a case report and literature review","authors":"JinFeng Chen , Min Ao , WeiYi Li , Xian Li , Li Yang","doi":"10.1016/j.rmcr.2025.102221","DOIUrl":"10.1016/j.rmcr.2025.102221","url":null,"abstract":"<div><div>Primary malignant melanoma of lung (PMML) are relatively rare, accounting for about 0.4 % of all malignant melanomas and only 0.01 % of all lung tumors, and PMML with distant metastases found at diagnosis is extremely rare. A case of PMML presented as multiple solid and ground glass pulmonary nodules with brain, liver,intrapulmonary and lymph nodes metastasis was reported in this study. A 42-year-old man had a headache for 10 days after symptomatic treatment in the department of neurology in our hospital, but the above symptoms did not improved. Multiple nodules were considered by head MRI. Chest CT showed two solid nodules in the upper and lower lobes of the right lung and multiple ground glass nodules in both lungs. To further clarify the diagnosis,CT-guided percutaneous puncture biopsy of pulmonary nodule was performed. The pathology revealed malignant melanoma of <lung>.NRAS + BRAF gene test, showing BRAF gene exon 15 V600E mutation Dalafenib and trametinib were given targeted therapy after discharge. After 1 month follow-up, all lesions were significantly decreased. PMML presenting as solid and ground glass pulmonary nodules with multiple metastases is extremely rare. The early identification of pathological biopsy and genetic testing is crucial for precise treatment and enhancing prognosis.</div></div>","PeriodicalId":51565,"journal":{"name":"Respiratory Medicine Case Reports","volume":"55 ","pages":"Article 102221"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143869764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mark A. Colantonio , Sanjana Aggarwal , Himanshu Deshwal
{"title":"Pulmonary artery aneurysm as a rare manifestation of Alpha-1 antitrypsin deficiency","authors":"Mark A. Colantonio , Sanjana Aggarwal , Himanshu Deshwal","doi":"10.1016/j.rmcr.2024.102164","DOIUrl":"10.1016/j.rmcr.2024.102164","url":null,"abstract":"<div><div>Alpha-1 antitrypsin is a relatively well-known genetic disease known to primarily affect the lungs and liver. Extrapulmonary manifestations of this disease have been reported, including vascular aneurysms. To date, few cases have reported vascular manifestations of this disease affecting the pulmonary vasculature. Here, we present a rare manifestation of alpha-1 antitrypsin deficiency leading to a saccular pulmonary artery aneurysm.</div></div>","PeriodicalId":51565,"journal":{"name":"Respiratory Medicine Case Reports","volume":"53 ","pages":"Article 102164"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143156449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Solitary metastasis in the internal auditory canal from non-small cell lung carcinoma: A case report","authors":"Julie De Boos , Marie Bruyneel , Ionela Bold","doi":"10.1016/j.rmcr.2025.102175","DOIUrl":"10.1016/j.rmcr.2025.102175","url":null,"abstract":"<div><h3>Background</h3><div>Metastases to the internal auditory canal (IAC) are exceedingly rare. This case report details the case of a patient with a history of locally advanced non-small cell lung carcinoma (NSCLC) who developed a solitary IAC metastasis.</div></div><div><h3>Case presentation</h3><div>A 59-year-old active smoker was initially diagnosed with a locally advanced, unresectable stage IIIA Pancoast tumor (NSCLC, cT4N1M0) and treated with concurrent chemoradiation (cisplatin-pemetrexed) followed by immunotherapy (durvalumab). A subsequent PET CT scan indicated a complete metabolic response. Eighteen months later, the patient presented with rapidly progressing vertigo, left-sided facial palsy, and hearing loss. MRI revealed enhancement on nerves VII and VIII, with no intracranial metastasis or leptomeningeal enhancement. A biopsy via an endoscope-assisted retrosigmoid approach confirmed that it was an NSCLC metastasis. Gamma knife radiosurgery was initiated, resulting in a favorable clinical and radiological response.</div></div><div><h3>Discussion</h3><div>IAC metastases are rare, representing only 0.3%–0.7 % of all lesions in this anatomical space. Lung cancer is a common primary source. Clinically, IAC metastases manifest with acute onset and rapid symptom progression, often mimicking benign conditions. MRI with gadolinium contrast is the imaging modality of choice. Biopsy, though challenging, is sometimes crucial for definitive diagnosis. Gamma knife radiosurgery is a promising treatment, offering potential preservation of hearing and tumor control.</div></div><div><h3>Conclusion</h3><div>This rare case underscores the importance of considering metastatic IAC lesions in patients with a history of malignancy, highlights the feasibility of a biopsy via retrosigmoid approach for diagnosis, and demonstrates the effectiveness of gamma knife radiosurgery.</div></div>","PeriodicalId":51565,"journal":{"name":"Respiratory Medicine Case Reports","volume":"53 ","pages":"Article 102175"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143155140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tomohito Okano , Hajime Fujimoto , Toshiyuki Ito , Atsushi Tomaru , Haruko Saiki , Tatsuki Tsuruga , Taro Yasuma , Corina N. D'Alessandro-Gabazza , Esteban C. Gabazza , Tetsu Kobayashi
{"title":"Endobronchial tuberculosis mimicking malignancy: Lessons from a case report","authors":"Tomohito Okano , Hajime Fujimoto , Toshiyuki Ito , Atsushi Tomaru , Haruko Saiki , Tatsuki Tsuruga , Taro Yasuma , Corina N. D'Alessandro-Gabazza , Esteban C. Gabazza , Tetsu Kobayashi","doi":"10.1016/j.rmcr.2025.102201","DOIUrl":"10.1016/j.rmcr.2025.102201","url":null,"abstract":"<div><div>Endobronchial tuberculosis is characterized by the presence of tuberculous lesions within the bronchi, irrespective of the formation of pulmonary lesions. When these lesions are visible, their morphology often raises the differential diagnosis of malignancy. Diagnostic challenges arise as sputum smear tests—crucial for mycobacterial identification—may yield negative results in up to half of the cases. Here, we present a 66-year-old male who exhibited clinical and radiological findings suggestive of malignancy but was ultimately diagnosed with endobronchial tuberculosis through a combination of bronchoscopy, histopathology, and polymerase chain reaction testing. The patient responded favorably to anti-tuberculosis therapy. This case underscores the importance of comprehensive diagnostic strategies for endobronchial tuberculosis, particularly in distinguishing it from tracheal malignancies.</div></div>","PeriodicalId":51565,"journal":{"name":"Respiratory Medicine Case Reports","volume":"55 ","pages":"Article 102201"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143746367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}